Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2026-01-22 @ 1:38 PM
Study NCT ID:
NCT02259556
Status:
RECRUITING
Last Update Posted:
2016-01-28
First Post:
2014-10-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive Lymphomas
Sponsor:
Chinese PLA General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-10
Start Date Type:
None
Primary Completion Date:
2018-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-10
Completion Date Type:
ESTIMATED
First Submit Date:
2014-10-05
First Submit QC Date:
None
Study First Post Date:
2014-10-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-01-26
Last Update Post Date:
2016-01-28
Last Update Post Date Type:
ESTIMATED